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Effects of acetate on energy metabolism and function in the isolated
perfused rat heart. Impairment of cardiac contractile function is an
important component of acetate associated hypotension during hemodi-
alysis treatments. We examined the effect of acetate on cardiac energy
metabolism using the isovolumic isolated perfused heart model. In this
preparation, acetate (10 M) caused decreases in tissue ATP concentrations
(2.3 0.8 vs. 15.6 1.0 /Lmol/g dry at 30 mm, P < 0.05) as well as
marked impairment of systolic function (dpdt = 863 135 vs. 1288 166
mm Hg/second at 30 mm, P < 0.05). Although altering perfusate calcium
concentrations (0.6, 1.2 and 2.4 mM) affected physiological responses to
acetate (5 and 10 mM), the reductions in tissue ATP concentrations were
similar. In isolated heart mitochondria, acetate (100 jM —10 mM)
selectively impaired octanoate and palmityl carnitine supported State 3
respiration in a dose dependent fashion (P < 0.01), but did not affect
respiration when succinate, pyruvate/malate or malate/glutamate was used
as substrate. We suggest that high concentrations of acetate selectively
impair fatty acid metabolism in heart issue. This in turn leads to decreases
in ATP production and tissue ATP concentrations that ultimately result in
impaired contractile function. As this occurs at relatively low concentra-
tions of acetate, this finding may be relevant to other parenterally-
administered acetate containing fluids.
Clinical administration of acetate as part of hemodialysis
treatments is known to be associated with hemodynamic embar-
rassment caused by vasodilation and impaired cardiac contractile
responses [11. However, it is not clear how much of the hemody-
namic instability associated with hemodialysis is related to acetate
in general and cardiac dysfunction, specifically [2, 3]. It should be
stressed that examining the mechanisms by which acetate may
impair cardiac contractile function in clinical subjects is not trivial.
Monitoring of cardiac function is generally performed noninva-
sively, which has some limitations. Moreover, assessment of
cardiac contractile function in the setting of marked changes in
preload and afterload which occur during hemodialysis treatments
is complex [3].
Whether acetate actually has direct adverse effects on cardiac
function and on cardiac energy metabolism is somewhat contro-
versial at this point. Starnes and coworkers report that acetate
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administration increases oxygen consumption and coronary blood
flow in isolated rat hearts as well as increases in the cytosolic
phosphorylation potential whereas Kiviluoma and colleagues find
decreases in tissue ATP concentrations when hearts were exposed
to acetate [4, 51.
To characterize the effects of acetate on cardiac energy metab-
olism as well as explore the mechanisms operant in any adverse
physiological effects of acetate, we chose to examine the effects of
acetate in the isolated rat heart preparation with physiological
monitoring and 31P NMR spectroscopy. To further define these
mechanisms, manipulations of perfusate calcium in the isolated
heart studies as well as detailed respiration studies of normal isolated
mitochondria utilizing different substrates were also performed.
METHODS
Animals
Male Sprague-Dawley (350 to 400 g) were used in these
experiments. Rats were anesthetized with Ketamine (1 mi/kg body
wt, 50 mg/dl) and Xylazine (0.6 mI/kg body wt, 20 mg/mI) prior to
surgery. The technique used for removal of the heart was as we
have previously reported [6].
Isolated heart perfusion methodology
A Langendorif heart preparation modified for serial nuclear
magnetic resonance spectroscopy (NMR) studies was employed.
Circuit design allowed for maintaining constant perfusion pres-
sure (usually 80 mm Hg) and temperature 37°C. The preparation
employed was isovolumic. The ventricular pressure was moni-
tored continuously using a latex balloon filled to achieve an
end-diastolic pressure of 8 to 12 mm Hg at the beginning of each
experiment without changing balloon volume for the duration of
the experiment. All hearts were first perfused for 30 minutes with
modified Krebs Henseleit saline supplemented with 11 m glu-
cose as substrate whose detailed composition we have reported
previously [6]. Specifically this perfusate contained 4 mmol/liter of
potassium and 1.2 mmol/liter of calcium. Subsequently, hearts
were subjected to 30 minutes of experimental perfusate where
sodium acetate was added at 5 and 10 m concentrations. A
control for the increased sodium was performed using 10 mrvt
sodium chloride. Following 30 minutes of experimental perfusion,
recovery perfusion was performed with standard for an additional
30 minutes. Note that during the baseline and recovery perfusion
periods, all hearts were perfused with our standard or "normal"
perfusate. All perfusates were gassed with 92.5% 02 and 7.5%
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Control (N = 6)
Baseline (30 mm) 60 4 1465 174 193 20 —1296 163 17 1
Experimental (60 mm) 62 5 1288 166 189 15 —1131 220 21 3
Recovery (90 mm) 55 5 1288 155 188 16 —1044 321 24 4
Acetate 10 mM LC (N = 6)
Baseline (30 mm) 58 10 1425 365 174 14 —913 279 10 3
Experimental (60 mm) 30 iO" 955 264" 142 30" —537 160" 14 12
Recovery (90 mm) so 11 1247 317 161 40 —793 221 12 3
Acetate 10 mM NC (N = 8)
Baseline (30 mm) 56 5 1448 66 221 14 —1440 204 18 2
Experimental (60 mm)
Recovery (90 mm)
36 5"44 4" 863 l35"859 153"' 204 17219 17 —802 iSS"—729 129" 29 3"27 7
Acetate 10 mat HC (N = 6)
Baseline (30 mm)
Experimental (60 mm)
53 850 8 1276 1591226 201 174 15173 21 —736 151—753 233
16 237 5"
Recovery (90 mm) 27 8"' 768 181"' 164 18 —415 128" 30 4"
Acetate 5 mat NC (N = 6)
Baseline (30 mm) 58 8 1499 149 216 21 —1083 108 18 3
Experimental (60 mm)
Recovery (90 mm)
35 535 4 907 126""848 121"" 215 17172 18" 726 118""—720 173h 35 10"30 11"
Time refers to minutes of the entire experiment. Results reported at the end of the Baseline, Experimental and Recovery periods. LC refers to low
perfusate calcium (11.6 mM), HC refers to high perfusate calcium (2.4 mM) and NC refers to normal perfusate calcium (1.2 mM). Data are expressed as
mean SCM. All P values are after Scheffe's correction for multiple comparisons.
P < 0.05, "P < 0.01 vs. Baseline by paired 1-test
P < 0.05, "P < 0.01 vs. Control by unpaired 1-test
CO2 which resulted in perfusate 02 tensions in excess of 400 torr.
and PCO2 tensions of approximately 40 torr. as previously re-
ported [6].
Nuclear magnetic resonance spectroscopy
All NMR spectroscopy studies were performed on a 7.05 Tesla
10 cm bore cryomagnet with AM 300 spectrometer (Bruker
Instruments, Billerica, MA, USA).
Serial 31P NMR spectra were obtained from isolated hearts
with a home-built slotted-gap resonator using 15 degree pulses (4
jss determined on isolated hearts) separated by 0.05 1 second
relaxation delays using a sweep width of 10 KHz and 1024 data
point arrays. Five minutes of acquisition time was employed for all
files. Data arrays were zero filled to 2048 data points prior to
exponential multiplication with 20 Hz linebroadening and Fourier
transformation. Signal-to-noise on all spectra exceeded 40:1.
Spectral peak assignments were made on the basis of chemical
shift. Relative peak areas were determined using an automated
Lorenzian linefitting routine, which optimized the linefit to exper-
imental data based on the least squares error method. Peak
position (that is, chemical shift), linewidth and intensity were
varied in this program written in our laboratory using Ouickbasic"'
[7]. The beta phosphate resonance of ATP was used for determi-
nation of ATI' concentrations. Relative concentrations were
determined from relative peak areas after correcting for partial
saturation. These relative chemical concentrations were converted
to absolute concentrations (smol/g dry) assuming an adenosine
triphosphate (ATP) concentration of 16 molIg dry based on
published values determined with conventional biochemical meth-
ods [8, 9] at the beginning of perfusion [10—12]. An external
standard using methylene diphosphate solution was used to
control for any changes in coil sensitivity. The intracellular pH
(pH,) was estimated based on the chemical shift of the inorganic
phosphate (Pi) resonance relative to the creatine phosphate (PCr)
resonance (a) according to the relationship pH = 6.8 + log10 [(a
3.4)1(5.7 — a')] [6].
Isolated mitochondria
In selected experiments, mitochondria were isolated from nor-
mal rat hearts in an identical manner to that which we have
previously reported [12]. The respiration of these isolated mito-
chondria was then studied using a computer based respirometer
with various substrates (malate/glutatmate, succinate, octanoate
and palmityl carnitine) both during and after coupling with ADP
(State 3 and State 4, respectively). The effects of adding acetate to
the reaction mixture on the respiration rates achieved with these
substrates was examined in these mitoehondria.
Statistical analysis
Data obtained were compared using one or two way analysis of
variance (ANOVA) and unpaired or paired Student's s-test with
Schefle's correction for multiple comparisons depending on the
unpaired or paired nature or the data [131. Statistical analysis was
performed using CRUNCH4 Software.
RESULTS
1he physiological responses to acetate and manipulations of
perfusate calcium arc summarized in Table I whereas the 31P
NMR spectral data are summarized in Table 2. The tables report
data obtained at the end of the baseline period (30 mm), the end
of the experimental period (60 mm) and the end of the recovery
period (90 mm). Hearts demonstrated stable hemodynamic and
metabolic parameters over the 90 minutes of when increased
perfusate sodium (150 compared with a normal of 140 mM) was
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Control (N = 6)
Baseline (30 mm) 16.1 0.5 28.8 1.6 10.2 1.1 8.4 1.2 7.09 0.04
Experimental (60 mm) 15.8 0.8 26.0 1.3 14.5 1.5 8.3 1.0 7.14 0.03
Recovery (90 mm) 15.2 0.8 27.8 1.5 12.6 1.6 8.3 1.8 7.10 0.04
Acetate 10 mM LC (N = 6)













Acetate 10 mM NC (N = 8)
Baseline (30 mm) 15.6 0.6 26.2 2.5 9.6 1.4 7.0 1.7 7.05 0.05
Experimental (60 mm) 12.3 0.5"' 22.3 2.0 12.2 1.5" 7.7 1.1 6.98 0.04
Recovery (90 mm) 10.9 1.3"' 27.2 1.2 12.4 1.7 7.4 1.6 7.06 0.04
Acetate 10 mtvi HC (N = 6)
Baseline (30 mm) 16.1 0.7 27.8 2.2 11.0 1.9 9.1 2.0 7.01 0.08
Experimental (60 mm) 12.6 0.6" 25.4 1.8 10.8 2.5 10.9 2.1 6.97 0.10
Recovery (90 mm) 11.1 0.6"' 25.8 1.7 11.3 2.5 11.1 1.3 7.00 0.08













Recovery (90 mm) 9.8 1.2" 28.9 2.3 13.0 2.0 9.2 1.5 7.10 0.04
Abbreviations are: Pi, inorganic phosphate; PM, phosphomonoesters; PCr, creatine phosphate. Time refers to minutes of the entire experiment.
Results reported at the end of the Baseline, Experimental and Recovery periods. LC refers to low perfusate calcium (0.6 mM), HC refers to high
perfusate calcium (2.4 mM), and NC refers to normal perfusate calcium (1.2 mM). Data are expressed as mean SEM. All P values are after Seheffe's
correction for multiple comparisons.
P < 0.05, "P < 0,01 vs. Baseline by paired t-test
"P < 0.05, "P < 0.01 vs. Control by unpaired t-test
Fig. 1. Stacked plot of 31P NMR spectra
obtained from a heart exposed to acetate.
Abbreviations are: B, baseline spectra
obtained after 30 minutes of perfusion under
normal conditions; El, E2 and E3 refer to
perfusion for 10, 20 and 30 minutes with 10
mM acetate added to normal perfusate; Rl,
R2 and R3 refer to recovery perfusion for 10,
20 and 30 minutes with normal perfusate.
Peak assignments are: 1, methylene
diphosphonate (MDP), an external standard;
2, phosphomonesters; 3, inorganic phosphate;
4, creatine phosphate; 5, yATP; 6, aATP; 7,
/3ATP.
employed (Control in Tables I and 2). In contrast exposure to
either 5 or 10 mrvt acetate resulted in a time dependent decreases
in ATP concentrations (Table 2 and Fig. 1), and physiological
changes consisting of decreases in developed pressure (DP) and
dp/dt as well as increase in left ventricular end diastolic pressure
(LVEDP) (Table 1). Both the physiological and metabolic effects
of 5 and 10 m acetate were similar.
Altering perfusate calcium did not appear to alter the 31P NMR
spectral response to 10 m acetate. However, exposure to acetate
in the presence of decreased perfusate calcium concentration
(0.6 mM) appeared to result in improved DP and dp!dt during
the recovery period. In contrast, exposure to acetate in the
presence of high perfusate calcium concentration (2.4 mM)
preserved systolic function during the experimental period hut
did not prevent decrease in DP and dp/dt during the recovery
period.
Isolated mitochondria exposed to acetate in the reaction media
displayed normal respiration responses with suecinate, pyruvate!
malate and malate/glutamate as substrates (Fig. 2). When acetate
alone was used as substrate, a very low State 3 respiration rate was
achieved. When octanoate was used as substrate, acetate resulted
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Fig. 2. Effect of 10 m acetate on mitochondrial respiration with differ-
ent substrates. Symbols are: (E) 10 m acetate alone; () malate and
glutamate (both 1.5 mM); () malate and glutamate (both 1.5 mM), +
acetate (10 mM); () suceinate (6 mM); () succinate (3 mM) + acetate(10 mM). State 2 refers to respiratory rate following addition of substrate,
State 3 refers to respiratory rate following addition of ADP and State 4
refers to respiratory rate when ADP is consumed. The addition of acetate
to either malate/glutamate or suecinate did not alter State 2, State 3 or
State 4 respiration rate significantly.
With palmityl carnitine, high concentrations of acetate also ap-
peared to impair State 3 respiration (Fig. 4).
DISCUSSION
Fig. 3. Effect of acetate on mitochondrial respiration with octanoate (42
aiM) as substrate. Symbols are: (E) no acetate; () 10 /tM acetate; () 100
LM acetate; () acetate 1 mM; () 10 m acetate. States 2, 3 and 4 as
defined in the Figure 2 legend. *p < 0.05 and ** < 0.01 versus No
acetate group.
Acetate has been used in clinical dialysate formulations for
many years [14, 15]. Although the acetate concentration used in
standard hemodialysis fluids has decreased substantially from
concentrations approaching 35 to 45 m since the advent of
"bicarbonate" proportioning systems, acetate concentrations of 2
to 8 m are still commonly employed [16]. Although dialysis
associated hypotension is multifactorial in nature, cardiovascular
instability related to unphysiological concentrations of acetate is a
mechanism that has been invoked by many authors [1, 2, 16].
Although cardiac ejection fraction values are not typically de-
creased during acetate hemodialysis associated hypotension, the
failure to see increases in cardiac contractile function in the
setting of decreased afterload suggests that acetate may be
directly cardiodepressent [3]. In vivo studies performed in exper-
imental animals support the concept that acetate may be directly
cardiodepressent [17].
The mechanism(s) by which acetate impairs cardiac function is
(are) still poorly understood. Acetate is apparently metabolized
primarily by acetyl-CoA synthetase which is expressed by a
number of tissues including liver and heart. Veech and Gitomer
have suggested that acetate metabolism through this enzyme may
decrease ATP concentrations as the net reaction generates a
pyrophosphate molecule and AMP as ATP is consumed [17].
These workers also found that exposure of experimental animals
to acetate and subsequent study of isolated liver mitochondria
Fig. 4. Effect of acetate on mitochondrial respiration with Palmityl
carnitine (10.6 ,LM) as substrate. Symbols are: () no acetate; () 10 zM
acetate; () 100 jLM acetate; () acetate 1 mM; () 10 m acetate. States
2, 3 and 4 are defined in the legend to Figure 2. 'P < 0.05 and ** < 0.01
versus No acetate group.
demonstrated abnormal respiration with a variety of substrates.
These authors suggested that pyrophosphate generation during
the metabolism of acetate led to mitochondrial calcium accumu-
lation with attendant respiratory dysfunction.
Starnes et al observed that isolated hearts perfused with acetate
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as substrate had increased oxygen consumption and coronary
blood flow as compared with hearts supported with glucose. Based
on conventional biochemical measurements of adenine nucleo-
tides, creatine and creatine phosphate, these authors felt that
hearts perfused with acetate had a higher phosphorylation poten-
tial, suggesting that they were metabolically "healthier" [41.
Kiviluoma et al also examined the effects of acetate on cardiac
function and metabolism. In an in vivo model, they found de-
creases in mean arterial pressure and increases in heart with
exposure to intravenous infusions of acetate, which resulted in
blood levels of about 2.0 to 2.5 m. In parallel studies performed
in the isolated perfused heart using conventional biochemical
methods, decreases in [ATP] concentrations were observed after
15 minutes of exposure to 2 m acetate [5]. Unfortunately,
neither of these groups reported measurements of contractile
function in the isolated perfused heart model [4, 5]. In our current
study, we observed that acetate at 5 and 10 m concentrations
produced marked functional impairment along with similar en-
ergy metabolic responses as reported by Kiviluoma et al [51. We
also found that administration of acetate in the setting of reduced
perfusate calcium improved physiological recovery from acetate
exposure during normal recovery perfusion. However, we did not
observe any increases in ATP during recovery perfusion regard-
less of the experimental perfusate calcium concentration. Our
results suggest that acetate exposure causes a decrease in contrac-
tile sensitivity to calcium that occurs in parallel with decreases in
ATP concentrations. Although it is appealing to suggest that the
decreases in ATP concentrations are responsible for the impaired
contractile function, further work is necessary to draw such
conclusions. We should also point out that we did not observe
increases in AMP concentrations which would appear as increases
in the phosphomonester resonance along with the decreases in
ATP. This would be expected if increases in AMP formation (due
to conversion of acetate to acetyl Co-A) explained the decrease in
ATP concentrations [41. However, rapid hydrolysis of AMP to
purine metabolites could explain this apparent discrepancy.
Our findings of isolated decreases in ATP concentrations with
exposure to acetate in the absence of changes in the concentra-
tions of PCr and Pi was somewhat unexpected. During situations
where energy production is suddenly impaired in the isolated
heart, decreases in [PCr] and increases in [Pu usually antedate any
changes in [ATP]. This has been observed during exposure to
hypoxia, metabolic acidosis, ischemia as well as metabolic poisons
in our laboratory [10, 12, 18] as well as many others [19—241. Such
changes in PCr and Pi concentrations have been used to infer
(based on an assumption of near equilibrium for the creatine
phosphokinase reaction) that in these settings, ADP concentra-
tions become elevated and ATP concentrations are "buffered"
[25]. However, increases in PCr without increases in ATP con-
centrations are commonly observed during reflow following isch-
emia [22, 26—29], and we have observed decreases in ATP to
occur in parallel to decreases in PCr in isolated hearts during
exposure to profound hypokalemia [30]. Differences in peripheral
utilization rates of ATP in these different pathological states may
account for some of these differences in the concentrations of high
energy phosphates. In the case of acetate exposure, we suggest
that decreases in mitochondrial energy production coupled with
possible increases in peripheral ATP utilization (suggested by the
increases in LVEDP) may explain this finding of selective ATP
depletion. Because this finding has been observed with both 31P
NMR spectroscopy in the present study and conventional bio-
chemistry methods [5], its veracity would seem solid.
Based on our work with isolated heart mitochondria, it appears
that acetate may impair respiration in a preparation where
calcium is essentially minimized in contrast to the calcium loading
mechanism discussed previously [4]. In our isolated mitochondria
preparation, exposure to acetate selectively impairs fatty acid
oxidation rather than causing a nonspecific impairment of respi-
ration. The mechanism by which this occurs is unclear. However,
it should be stressed that the dose-response curve of acetate
impairing State 3 respiration with octanoate was inconsistent with
the published Km for acetyl CoA synthetase [17], supporting the
concept that acetate may impairing coupled respiration of fatty
acids through a different mechanism. Although in our isolated
perfused heart preparation, fatty acids are not added to the
perfusate as substrate, other authors have pointed out the impor-
tance of endogenous fat metabolism in this setting [3 1—33].
Therefore, these isolated heart perfusion results are consistent
with the data obtained with isolated heart mitochondria.
In summary, we observed that acetate was cardiodepressent at
concentrations achieved clinically during acetate hemodialysis
using the isolated perfused heart model. Moreover, acetate expo-
sure resulted in significant decreases in ATP concentrations which
were not affected by manipulations of perfusate calcium and did
not reverse upon reinstitution of normal perfusion conditions.
Studies in isolated heart mitochondria suggest that acetate in-
duced impairment of fatty acid metabolism is involved in these
reductions in myocardial ATP concentrations.
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